Bandingkan Harga & Kinerja Prima Andalan Mandiri Tbk. (MCOL) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Prima Andalan Mandiri Tbk. dan Organon Pharma Indonesia Tbk.: Prima Andalan Mandiri Tbk. diperdagangkan di Rp3.690 (kapitalisasi pasar 13,19 T, volume 24 jam 22,6 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Prima Andalan Mandiri Tbk. jauh lebih besar — sekitar 126,3× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| MCOL | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 13,19 T | 104,4 M |
Volume | 22,6 rb | — |
Lot | 226 | — |
Perputaran | 82,96 jt | — |
Harga Rata-rata | 3.670,71 | — |
Nilai Transaksi | 82,96 jt | — |
Harga Ekuilibrium Indikatif | 3.690 | — |
Volume Ekuilibrium Indikatif | 5 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Prima Andalan Mandiri Tbk.
PT Prima Andalan Mandiri Tbk (the Company) is a limited liability company established in the Republic of Indonesia based on Notarial Deed of Nurul Hidajati Handoko, S.H., No. 1 dated June 1, 2005. The Company started commercial activities in 2011.
Selengkapnya di halaman MCOL →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
